LEP and atherosclerosis: Therefore, one can soundly anticipate that metreleptin will significantly reduce the risk for atherosclerosis in lipodystrophy patients through centrally orchestrated mechanisms reducing food intake but also through direct and local effects of leptin activating β-oxidation of fatty acids and preventing lipogenesis in the liver and skeletal muscles98.